Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Caitlin Truesdale

BioCT welcomes new member Ciencia

Ciencia’s patented Centinela system aims to provide on-site laboratory-quality answers to key clinical questions, ultimately permitting clinical evaluation, laboratory diagnosis, and therapy initiation during the...

| By Caitlin Truesdale

AI Therapeutics acquires Spanish cancer drug

Guilford-based AI Therapeutics, a drug company founded by entrepreneur Jonathan Rothberg, has acquired a new cancer drug candidate from Spain’s EntreChem, S.L. The new candidate, EC-8042...

| By Caitlin Truesdale

HBJ/NHB ‘Best Places to Work in CT’

“This year’s honorees have gone above and beyond to find creative, strategic, and safe ways to make work fun, inclusive and forward-thinking places for employees...

| By Caitlin Truesdale

Weekly Roundup – April 28, 2022 

View this email in your browser Weekly Roundup – April 28, 2022                           ...

| By Caitlin Truesdale

UConn appoints BI Pharmaceuticals chair

The UConn Board of Trustees has approved the appointment of José Manautou, Department Head of Pharmaceutical Sciences and Professor of Pharmacology & Toxicology, as the School of...

| By Caitlin Truesdale

Besides its psych drug, BioXcel to focus on oncology

After having won FDA approval for the psychiatric drug Igalmi, BioXcel is making a major new move: pivoting its focus to commercialization and spinning out much of...

| By Caitlin Truesdale

Career News – April 26, 2022 

View this email in your browser Career News – April 26, 2022                         Golden Ticket...

| By Caitlin Truesdale

LambdaVision sets sights on artificial retina

LambdaVision’s signature product — an artificial retina that could change the lives of thousands with degenerative eye diseases — is under development aboard the International...

| By Caitlin Truesdale

Biohaven’s Nurtec decreases opioid use re migraine

New data show that migraine patients treated with Biohaven’s Nurtec ODT decreased their use of opioids. “Results demonstrate a clinically meaningful reduction in opioid use in...